![Frank Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Thomas
Presidente presso
SPERO THERAPEUTICS, INC.
Patrimonio netto: 187 100 $ in data 30/06/2026
Profilo
Frank E.
Thomas is Chairman at Spero Therapeutics, Inc. since 2025.
Holds director positions at Orchard Therapeutics North America and Larimar Therapeutics, Inc. since 2014.
Serves as President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd. since 2020 and at Orchard Therapeutics Plc since 2018.
Former roles include President, Chief Executive Officer & Director at Critical Therapeutics, Inc. from 2006 to 2008; Controller & Finance Director at Mechanical Dynamics, Inc. from 1997 to 2000; Independent Director at Zafgen, Inc.; Director at Massachusetts Biotechnology Council from 2007 to 2015; Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc. from 2000 to 2004; Chief Operating Officer & Senior Vice President at Molecular Biometrics, Inc. from 2010 to 2011; Principal at Arthur Andersen LLP from 1992 to 2000; and President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate studies at the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/06/2026 | 75.000 ( 0,13% ) | 165 750 $ | 30/06/2026 | |
| 19/05/2026 | 7.000 ( 0,01% ) | 21 350 $ | 30/06/2026 |
Posizioni attive di Frank Thomas
| Società | Posizione | Inizio |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Presidente | 10/01/2025 |
| ORCHARD THERAPEUTICS PLC | Presidente | 18/03/2020 |
| LARIMAR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2014 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Presidente | 17/03/2020 |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Frank Thomas
| Società | Posizione | Fine |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Amministratore Delegato | 14/05/2012 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direttore/Membro del Consiglio | 01/01/2015 |
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Direttore Finanziario/CFO | 18/01/2010 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Amministratore Delegato | 31/03/2008 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Frank Thomas
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Mechanical Dynamics, Inc.
 Mechanical Dynamics, Inc. Information Technology ServicesTechnology Services Develops, markets, and supports virtual prototyping solutions | Technology Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Commercial Services |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
